Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy

Mohamad Arow(Tel Aviv University), Michael Arad(Tel Aviv University)

Cardiovascular Diabetology

January 10, 2020

10.1186/s12933-019-0980-4

Cited by 227

Related Papers

No related papers found

Powered by citation graph analysis